Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

ICOSLG Antikörper (AA 23-149)

Der Maus Monoklonal anti-ICOSLG Antikörper wird verwendet zum Nachweis von ICOSLG in Proben von Human. Er wurde validiert für ELISA, FACS, IF und IHC (p).
Produktnummer ABIN7872486
312,40 €
Zzgl. Versandkosten 20,00 € und MwSt
20 μg
Lieferung nach: Deutschland
Lieferung in 6 bis 9 Werktagen

Kurzübersicht für ICOSLG Antikörper (AA 23-149) (ABIN7872486)

Target

Alle ICOSLG Antikörper anzeigen
ICOSLG (Inducible T-Cell Co-Stimulator Ligand (ICOSLG))

Reaktivität

  • 116
  • 18
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Human

Wirt

  • 58
  • 57
  • 8
  • 5
  • 1
Maus

Klonalität

  • 86
  • 42
  • 1
Monoklonal

Konjugat

  • 73
  • 10
  • 8
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Dieser ICOSLG Antikörper ist unkonjugiert

Applikation

  • 53
  • 42
  • 40
  • 38
  • 20
  • 18
  • 15
  • 12
  • 5
  • 4
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
ELISA, Flow Cytometry (FACS), Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Klon

ICOSL-3111
  • Bindungsspezifität

    • 29
    • 7
    • 5
    • 5
    • 5
    • 4
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 23-149

    Verwendungszweck

    ICOSLG Antibody / ICOS Ligand / B7RP-1

    Aufreinigung

    Protein G affinity chromatography

    Immunogen

    A recombinant fragment of human ICOS Ligand / B7RP-1 protein within amino acids 23-149 was used as the immunogen for the ICOSLG antibody.

    Isotyp

    IgG1, kappa
  • Applikationshinweise

    Optimal dilution of the ICOSLG antibody should be determined by the researcher.
    1. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Konzentration

    0.2 mg/mL

    Buffer

    0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced) and 0.05 % sodium azide

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    4 °C,-20 °C

    Informationen zur Lagerung

    Store the ICOSLG antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
  • Target

    ICOSLG (Inducible T-Cell Co-Stimulator Ligand (ICOSLG))

    Andere Bezeichnung

    ICOSLG

    Hintergrund

    This MAb recognizes a protein of 36 kDa, identified as ICOSLG, which is also known as B7-related protein-1 (B7RP-1).T-cell co-stimulatory molecule, inducible co-stimulator (ICOS)/B7-related protein-1 (B7RP-1, B7-H2, GL50, ICOS-L) is a ligand for the ICOS receptor that initiates T and B cell proliferation and cytokine secretion. ICOS-L interactions play an essential role in T cell-dependent B cell activation in peripheral lymphoid organs such as spleen and lymph nodes. ICOS-L protein is present in myeloid leukocytes, and by northern blot there are 2.4, 3.0, and 7.0 kb transcripts in brain, heart, kidney, and liver, with lower expression in colon and thymus, and a 1.1 kb transcript in leukocytes. Tumor necrosis factor alpha (TNFi±), granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-4 (IL-4) enhance its expression. LPS-induced up-regulation of ICOS-L is dependent on the MyD88-dependent signaling pathway.

    UniProt

    O75144

    Pathways

    Production of Molecular Mediator of Immune Response, Activated T Cell Proliferation
Sie sind hier:
Chat with us!